According to a report published by the Kaiser Family Foundation (KFF), Medicaid spending growth is expected to decrease. This comes as nearly 11 million beneficiaries have been dropped from Medicaid since April 1 of this year following redeterminations. However, enhanced federal match funding will be phased out over the next year, causing the states’ proportion of Medicaid expenditures to increase (Inside Health Policy, November 21; Inside Health Policy, November 21; Epic Research, November 17).
Based on CMS’ most recent data, 25 states have submitted 1915(c) waiver amendments to extend Appendix K flexibilities that were first approved during the COVID-19 public health emergency (PHE), including nine states that are seeking approval to improve support for family caregivers. The most common flexibilities states have requested are implementing rate increases or supplemental payments, adding telehealth or remote patient monitoring, and adding relative caregivers as service providers (Inside Health Policy, November 22).
On November 22, bipartisan senators sent a letter to the U.S. Health and Human Services’ Office of Inspector General calling for an investigation into payers. The letter included a recent Wall Street Journal report that cited some payers are paying much more for drugs when cheaper generic versions are available (Inside Health Policy, November 22).
From November 22 to November 28, CMS approved nine SPAs and has one 1115 waiver amendment out for public comment.